Several pharmaceutical companies are placing big bets on exosomes and other extracellular vesicles as a means to deliver nucleic acid therapeutics.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Engineered extracellular vesicle-encapsulated CHIP as novel nanotherapeutics for treatment of renal fibrosis
npj Regenerative Medicine Open Access 13 January 2024
-
Edible and cation-free kiwi fruit derived vesicles mediated EGFR-targeted siRNA delivery to inhibit multidrug resistant lung cancer
Journal of Nanobiotechnology Open Access 05 February 2023
-
Extracellular vesicles: from bench to bedside
Current Medicine Open Access 26 May 2022
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zipkin, M. Big pharma buys into exosomes for drug delivery. Nat Biotechnol 38, 1226–1228 (2020). https://doi.org/10.1038/s41587-020-0725-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-020-0725-7
This article is cited by
-
Engineered extracellular vesicle-encapsulated CHIP as novel nanotherapeutics for treatment of renal fibrosis
npj Regenerative Medicine (2024)
-
Exploiting sound for emerging applications of extracellular vesicles
Nano Research (2024)
-
Edible and cation-free kiwi fruit derived vesicles mediated EGFR-targeted siRNA delivery to inhibit multidrug resistant lung cancer
Journal of Nanobiotechnology (2023)
-
Recent advances in anti-inflammatory active components and action mechanisms of natural medicines
Inflammopharmacology (2023)
-
Extracellular vesicles: from bench to bedside
Current Medicine (2022)